with Candida identified in the microbiome. 6 In addition, human breast milk is known to have many host defense components, including immunoglobulins, lactoferrin, mucins, dermcidin, and clusterin, 7 several of which are fungicidal 8 or inhibit fungal colonization of human mucosae. 9 Studies have also demonstrated that administration of bovine lactoferrin to premature infants is associated with reductions in late-onset sepsis and invasive fungal infection without altering Candida colonization, 10 but in general, data regarding the role of specific human milk components in the colonization of the neonatal gut and development of the neonatal microbiome are emerging.
In this study, we investigate human host defense protein content in expressed human milk and the relationship with infant fungal colonization. We hypothesized that the concentration of host defense proteins in human milk fed to infants would vary between yeast-colonized and yeast-uncolonized infants.
Methods
The study design has been reported previously. 4 Briefly, infants were enrolled from the neonatal intensive care unit (NICU) at Women & Infants Hospital of Rhode Island. The sole inclusion criterion was admission to the NICU with a minimum stay of 72 hours. Exclusion criteria included death, transfer, or discharge from the NICU at less than 72 hours of age and lack of parental informed consent. Cultures of expressed breast milk and swabs from oropharynx, inguinal, and rectal sites of infants were obtained at enrollment and then weekly for 12 weeks, or until the patient exited the study due to discharge from the hospital, transfer, or death. Breast milk and swabs were cultured for yeast. An infant was defined to be colonized if yeast was recovered from any site at any point during participation in the study. Yeast isolates were primarily Candida species, but Trichosporon species were also isolated. Expressed breast milk (0.5 mL) from each infant's mother was obtained from the daily supply and may have been freshly expressed and refrigerated or may have been frozen and thawed prior to being refrigerated. No donor breast milk was used in this cohort. Samples were transported in sterile polystyrene tubes. Following culture, residual breast milk samples with volumes of approximately 250 to 300 µL were subsequently cryopreserved at −80°C in Nunc cryotubes (Thermo Scientific, Waltham, Massachusetts, USA) until analysis. The study was approved by the institutional review board of Women & Infants Hospital, and data extraction and storage complied with the Health Information Portability and Accountability Act of 1996.
Cultures and Identification
Milk and swabbed samples were cultured on YPD agar media (1% yeast extract, 2% peptone, 2% dextrose, 2% agar) containing 100 µg/mL of streptomycin and 50 µg/mL of ampicillin to inhibit bacterial growth, and yeast isolates were identified using the Vitek-2 system (bioMérieux, Marcy L'Étoile, France).
Measurement of Host Defense Proteins
Breast milk samples were originally collected for the purpose of culturing for yeast. Remaining samples from both the colonized and uncolonized cohorts were available for testing in the present study. Midway through the study, the informed consent document was changed to allow for testing of host defense proteins. Samples collected prior to this change could not be used for measurement of host defense proteins. This change excluded 69 infants, leaving 61 infants eligible for this analysis, which was fewer than anticipated. For some subjects, multiple milk samples from the same infant-mother pair from different time points were available to be tested. A convenience sample of available stored specimens from colonized and uncolonized groups was selected for testing. All available colonized subjects were included when there was an adequate residual specimen for an assay. Samples from the uncolonized cohort were selected based on having adequate volume for the assay. Commercial ELISA kits were used to test for human lactoferrin, lysozyme, apolipoprotein J (Abcam, Cambridge, Massachusetts, USA), soluble CD14 (Sigma Aldrich, St Louis, Missouri, USA), human mucin-1, and dermcidin (USCN Life Science, Hubei, China). Samples were tested in duplicate on 1 assay, with sets of standards run in duplicate or triplicate depending on manufacturers' instructions.
Statistical Analysis
Statistical analyses were performed using SAS 9.3 (SAS Institute, Cary, North Carolina, USA). Samples from the colonized cohort and uncolonized cohort were analyzed as individual specimens using negative binomial models with generalized estimating equations adjustment to account for lack of independence among samples attributed to the same patient. For these analyses, Proc Genmod was used, specifying an exchangeable correlation structure. A 2-sided P value of < .05 was considered statistically significant.
Results
A total of 130 patients from 2276 total admissions during this time period were recruited from February 2011 to November 2012. Follow-up extended through December 2012. Cultures were obtained on 129 subjects; cultures were unable to be obtained from 1 patient due to medical instability. The yeast colonization rate was 22%. Results from the entire cohort have been reported in detail elsewhere. 4 Of the original 129 subjects with culture data available, 61 infants were eligible for inclusion in the present study. In this subgroup, 16% were colonized, all with Candida species. A total of 5 colonized infants were identified in the subcohort: 3 of the 5 infants contributed multiple breast milk samples. It is notable that only 1 infant received breast milk that was colonized with yeast; the organism recovered from breast milk was C lusitaniae, whereas the organism recovered from the infant was C parapsilosis.
Infants in this NICU during the time of the study were preferentially fed mother's breast milk. Parenteral nutrition was also used until infants achieved full enteral feeds. Days receiving parenteral nutrition are presented as an estimate of when infants achieved full feeds, shown in Table 1 . Median duration of parenteral nutrition was slightly longer in the uncolonized group. Weekly breast milk samples were obtained; estimates of transition to exclusive formula feeding are obtained with the total number of breast milk samples, which was longer in the uncolonized group. None of the differences in Table 1 including exclusive breast milk feeding, length of stay, or days on parenteral nutrition were found to be statistically significant.
The number of samples tested for each assay is presented in Table 2 . In an attempt to increase power, multiple milk samples attributed to a single subject, but obtained at different time points, were analyzed. Lack of independence among samples attributed to a single subject was taken into account in the statistical modeling. Concentrations of apolipoprotein J, lactoferrin, and mucin-1 did not differ between the colonized and uncolonized groups ( Table 2 ). However, lysozyme and dermcidin concentrations were significantly higher in the uncolonized group than the colonized group. Conversely, soluble CD14 was higher in the colonized group compared with the uncolonized group. Individual measurements of each component for all samples are depicted graphically in Figure 1 .
Discussion
Systemic candidiasis represents an important cause of morbidity and mortality in premature neonates, 1 and recent evidence suggests that breast milk can alter infant fungal colonization. 4 Data presented here suggest that there may be an association between lysozyme and dermcidin concentrations in expressed breast milk and colonization with yeast in a neonatal intensive care setting when individual milk samples were analyzed, taking into account that subjects may have contributed more than 1 milk specimen. Concentrations of the host defense proteins, lysozyme and dermcidin, were lower in breast milk given to infants colonized with yeast than in the breast milk given to uncolonized infants. This raises the question of whether bioactive content, in addition to timing, caloric content, and nutrition content, should be a consideration in the decisions regarding feeding neonates in the intensive care setting. More rigorously designed studies are needed to better characterize potential relationships between composition of breast milk and colonization with yeast.
The association of lysozyme levels with yeast colonization is consistent with animal models of the gut microbiome. 11 Studies in which goat milk was genetically modified to contain human lysozyme showed alterations in the microbiome of the recipient goat compared to a conventionally fed control animal. At 14 days, the human lysozyme-fed goats had higher levels of Bacteroidetes and lower levels of Firmicutes compared to the conventionally fed goats. It is speculated that lysozyme helped select for beneficial bacteria in the goat microbiome. 11 Dermcidin is a cationic human host defense peptide secreted by the eccrine glands and was first described by Schittek and colleagues in 2001. 12 Dermcidin shows no homology to known defensins or cathelicidins. This peptide has in vitro antimicrobial activity against Candida albicans, as well as Escherichia coli, Staphylococcus aureus, and Enterococcus faecalis. 12 To our knowledge, dermcidin levels in breast milk have not been previously associated with fungal colonization status. Mechanisms of dermcidin's effects on colonization status were not examined in this study.
CD14 was observed to be somewhat higher in the colonized group when analyzed by sample. It is unclear from this study by what mechanism, if any, this association translates to fungal colonization. Soluble CD14 may play a role in establishment of gut bacteria and has been shown to play a role in activating the innate immune response to lipopolysaccharide (LPS) carried by E coli and other bacteria. 13 In addition, LPS has been shown to enhance phagocytosis of Candida through induction of expression of dectin-1 in human peripheral blood monocytes. 14 One mechanism may be that higher levels of CD14 reduce E coli and other Gramnegative colonization and thus LPS exposure, making the environment more favorable for Candida. There are likely other complex interactions between host bacteria, fungi, and the immune system that are affected by CD14, which this study was not designed to examine.
This study has several important limitations. As an observational study, causal relationships cannot be determined. Although the original study sample was sufficiently powered to investigate relationships, specifically the relationship between breast milk colonization and infant colonization, the current study was designed as a post-hoc analysis. The investigation was thus limited to an analysis of a much smaller subgroup of patients with cryopreserved samples of infants' mother's milk. The volume of breast milk obtained was not sufficient to allow for separate aliquots for testing of multiple substances, and the samples may have been degraded through repeated freeze-thaw cycles. Internal studies show a degradation of lactoferrin with multiple freeze-thaw cycles. Additional studies on freeze-thaw cycle were not able to be performed for the other substances due to the volume of milk. Nonetheless, degradation would most likely result in a type II error, lending more support that the differences found are true findings. It is possible that negative findings from this study are false negatives and that studies on fresh specimens would have different, significant findings.
Conclusion
The results presented here provide evidence for a relationship between the host defense protein composition of the breast milk and infant yeast colonization, particularly with respect to lysozyme and dermcidin. The source of the host defense proteins may not be the breast milk itself but, rather, contact with maternal or infant skin secretions, which could not be assessed in this study. Breast milk is also known to change in composition over time. Examination of this change in composition with relation to colonization status would elucidate temporal relations and help determine causal relationships. Future studies to address these issues would include rigorously designed investigations to examine the relationship between the composition of breast milk and fungal colonization status. Molecular techniques could be used to determine the burden of organisms, along with their relationship with other commensal organisms on the skin and in the gastrointestinal tract.
